https://ntp.niehs.nih.gov/go/17421

TDMS Study 99034-01 Pathology Tables

NTP Experiment-Test: 99034-01  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03
Route: GAVAGE                                                                                                     Time: 14:53:39
                                                         FINAL #1 MICE
       Facility:  Battelle Columbus Laboratory
       Chemical CAS #:  71-43-2
       Lock Date:  10/15/01
       Cage Range:  All
       Reasons For Removal:    All
       Removal Date Range:     All
       Treatment Groups:       Include All
a  Number of animals examined microscopically at site and number of animals with lesion
                                                              Page   1
NTP Experiment-Test: 99034-01  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03  
Route: GAVAGE                                                                                                     Time: 14:53:39  
____________________________________________________________________________________________________________________________________
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially in Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
    Terminal Sacrifice                                15           15           15           15           15                        
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   Ovary                                              (14)         (15)         (15)         (15)         (15)                      
      Histiocytic Sarcoma                                           2 (13%)                                                         
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   Bone Marrow                                        (15)         (15)         (15)         (15)         (15)                      
                                                             Page   2                                                               
NTP Experiment-Test: 99034-01  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03  
Route: GAVAGE                                                                                                     Time: 14:53:39  
____________________________________________________________________________________________________________________________________
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM - cont                                                                                                         
      Histiocytic Sarcoma                              3 (20%)      2 (13%)                                3 (20%)                  
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 SYSTEMIC LESIONS                                                                                                                   
   Multiple Organs                                   *(15)        *(15)        *(15)        *(15)        *(15)                      
      Histiocytic Sarcoma                              3 (20%)      3 (20%)                                3 (20%)                  
____________________________________________________________________________________________________________________________________
     *   Number of animals with any tissue examined microscopically                                                                 
                                                             Page   3                                                               
NTP Experiment-Test: 99034-01  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03  
Route: GAVAGE                                                                                                     Time: 14:53:39  
____________________________________________________________________________________________________________________________________
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
TUMOR SUMMARY                                                                                                                       
   Total Animals with Primary Neoplasms (b)             3           3                                   3                           
     Total Primary Neoplasms                            3           3                                   3                           
   Total Animals with Benign Neoplasms                                                                                              
     Total Benign Neoplasms                                                                                                         
   Total Animals with Malignant Neoplasms               3           3                                   3                           
     Total Malignant Neoplasms                          3           3                                   3                           
   Total Animals with Metastatic Neoplasms                                                                                          
     Total Metastatic Neoplasm                                                                                                      
   Total Animals with Malignant Neoplasms                                                                                           
   Uncertain Primary Site                                                                                                           
   Total Animals with Neoplasms Uncertain-                                                                                          
   Benign or Malignant                                                                                                              
     Total Uncertain Neoplasms                                                                                                      
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Primary tumors: all tumors except metastatic tumors                                                                              
                                                             Page   4                                                               
NTP Experiment-Test: 99034-01  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03  
Route: GAVAGE                                                                                                     Time: 14:53:39  
____________________________________________________________________________________________________________________________________
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially in Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                                                                     1                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                15           15           15           15           14                        
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   Adrenal Cortex                                     (15)         (15)         (15)         (15)         (15)                      
   Thyroid Gland                                      (15)         (15)         (15)         (15)         (15)                      
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   Epididymis                                         (15)         (15)         (15)         (15)         (15)                      
   Testes                                             (15)         (15)         (15)         (15)         (15)                      
____________________________________________________________________________________________________________________________________
                                                             Page   5                                                               
NTP Experiment-Test: 99034-01  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03  
Route: GAVAGE                                                                                                     Time: 14:53:39  
____________________________________________________________________________________________________________________________________
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   Bone Marrow                                        (15)         (15)         (15)         (15)         (15)                      
   Lymph Node                                         (11)         (11)         (12)         (9)          (7)                       
   Lymph Node, Mandibular                             (15)         (15)         (15)         (14)         (14)                      
   Lymph Node, Mesenteric                             (15)         (15)         (14)         (15)         (15)                      
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   Brain                                              (15)         (15)         (15)         (15)         (15)                      
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   Eye                                                                                                    (1)                       
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
                                                             Page   6                                                               
NTP Experiment-Test: 99034-01  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03  
Route: GAVAGE                                                                                                     Time: 14:53:39  
____________________________________________________________________________________________________________________________________
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
 SYSTEMIC LESIONS                                                                                                                   
   Multiple Organs                                   *(15)        *(15)        *(15)        *(15)        *(15)                      
      Lymphoma Malignant                                                                                   5 (33%)                  
____________________________________________________________________________________________________________________________________
     *   Number of animals with any tissue examined microscopically                                                                 
                                                             Page   7                                                               
NTP Experiment-Test: 99034-01  INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)      Report: PEIRPT05
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03  
Route: GAVAGE                                                                                                     Time: 14:53:39  
____________________________________________________________________________________________________________________________________
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
TUMOR SUMMARY                                                                                                                       
   Total Animals with Primary Neoplasms (b)                                                             5                           
     Total Primary Neoplasms                                                                            5                           
   Total Animals with Benign Neoplasms                                                                                              
     Total Benign Neoplasms                                                                                                         
   Total Animals with Malignant Neoplasms                                                               5                           
     Total Malignant Neoplasms                                                                          5                           
   Total Animals with Metastatic Neoplasms                                                                                          
     Total Metastatic Neoplasm                                                                                                      
   Total Animals with Malignant Neoplasms                                                                                           
   Uncertain Primary Site                                                                                                           
   Total Animals with Neoplasms Uncertain-                                                                                          
   Benign or Malignant                                                                                                              
     Total Uncertain Neoplasms                                                                                                      
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Primary tumors: all tumors except metastatic tumors                                                                              
                                                             Page   8                                                               
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------